BOARDS/COMMISSIONS: Provides for the Drug Policy Board
HB 316 establishes the Drug Policy Board to advise on state drug policy matters. The bill creates the board structure and specifies that one member must be a representative "of" a specific organization (as clarified by an amendment changing "from" to "of"). This procedural bill does not change existing drug laws or policies but outlines the board's formation. It directly affects the state's health and welfare agencies by creating a new advisory body. The bill is currently in its third reading stage after committee approval.
Bill status
signed
all 5 stages cleared
Introduction
Apr 2025
Committee Review
May 2025
House Passage
Apr 2025
Senate Passage
May 2025
Signed into Law
Jun 2025
Introduced Apr 2, 2025
Signed Jun 4, 2025
Maddy AI version diff · 4 comparisons
What changed between versions
HB316 Original
→
HB316 Act 78
·
4 edits
MODERATE
The bill was finalized as Act No. 78, removing the original prefile notice and reordering the list of statutes to amend. The core policy language was updated to use more modern terms like 'substance misuse' instead of 'abuse of drugs and alcohol.' The Drug Policy Board's duties were expanded to include evaluating the effectiveness of prevention programs and addressing challenges in enforcing drug laws.
Scope change
The bill's scope remains focused on the Drug Policy Board, but the specific statutes referenced were reordered, and the Board's mandate was broadened to include law enforcement evaluation.
DEFINITION
Updated terminology from 'abuse of drugs and alcohol' to 'substance and alcohol misuse' to reflect modern language.
REQUIREMENT
Added a specific duty for the Board to evaluate the effectiveness of state and local public awareness, prevention, and harm reduction programs.
Added a specific duty for the Board to evaluate challenges in enforcing drug laws and make recommendations for legislative or executive improvements.
TECHNICAL
Reordered the list of Revised Statutes to be amended and removed the original prefile notice regarding the Drug Policy Board.
Floor votes · Senate May 28, 2025 · House Apr 24, 2025
How they voted
36–0
Passed · 1 other
Total votes 37
May 28, 2025
D
Democratic11
100% Yea
R
Republican26
96% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
19
Key actions
4
Committee
5
May 28, 2025
Upper · Passed
Read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
May 19, 2025
Committee
Read by title and referred to the Legislative Bureau.
upper
May 14, 2025
Upper · Passed
Reported favorably.
upper
Apr 24, 2025
Lower · Passed
Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate.
lower
Apr 16, 2025
Lower · Passed
Reported with amendments (14-0).
lower
Apr 14, 2025
Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
lower
Apr 2, 2025
Committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Rhonda Butler
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 316
Scope: LA
Hi! I can help you understand HB 316. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline